Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus

Annual Review of Nutrition

Volumn 36, Issue , 2016, Pages 337-367

  Koliaki, Chrysi ^a,b   Roden, Michael ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Bioenergetic adaptation; Insulin resistance; Mitochondrial dynamics; Mitochondrial function; Oxidative phosphorylation; Tissue specificity

Indexed keywords

INSULIN;

ADIPOSE TISSUE; BIOENERGY; CARDIAC MUSCLE; CLINICAL ASSESSMENT; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; EPIDEMIOLOGY; FATTY LIVER; HUMAN; INFORMATION RETRIEVAL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MEDLINE; METABOLIC DISORDER; MITOCHONDRIAL DYNAMICS; MITOPHAGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE PHOSPHORYLATION; PLASTICITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE SPECIFICITY; TURNOVER TIME; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; ENZYMOLOGY; EVIDENCE BASED MEDICINE; INSULIN DEPENDENT DIABETES MELLITUS; LIVER MITOCHONDRION; METABOLISM; MITOCHONDRION; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PATHOPHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; HUMANS; INSULIN RESISTANCE; MITOCHONDRIA; MITOCHONDRIA, LIVER; MITOCHONDRIAL TURNOVER; MODELS, BIOLOGICAL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; ORGAN SPECIFICITY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS;

EID: 84978945643     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071715-050656     Document Type: Review

References (137)

1. Abdelmalek MF, Lazo M, Horska A, Bonekamp S, Lipkin EW, et al. 2012. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 56:952-60
2. Adjeitey CN,Mailloux RJ, deKemp RA, Harper ME. 2013. Mitochondrial uncoupling in skeletalmuscle by UCP1 augments energy expenditure and glutathione content while mitigating ROS production. Am. J. Physiol. Endocrinol. Metab. 305:E405-15
3. Anderson EJ, Kypson AP, Rodriguez E, Anderson CA, Lehr EJ, Neufer PD. 2009. Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J. Am. Coll. Cardiol. 54:1891-98
4. Anderson EJ, Rodriguez E, Anderson CA, Thayne K, Chitwood WR, Kypson AP. 2011. Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways. Am. J. Physiol. Heart Circ. Physiol. 300:H118-24
5. Antoun G, McMurray F, Thrush AB, Patten DA, Peixoto AC, et al. 2015. Impaired mitochondrial oxidative phosphorylation and supercomplex assembly in rectus abdominis muscle of diabetic obese individuals. Diabetologia 58:2861-66
6. Bach D, Naon D, Pich S, Soriano FX, Vega N, et al. 2005. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor αand interleukin-6. Diabetes 54:2685-93
7. Befroy DE, Kibbey RG, Perry RJ, Petersen KF, Rothman DL, et al. 2015. Response to Burgess. Nat. Med. 21:109-10
8. Befroy DE, Perry RJ, Jain N, Dufour S, ClineGW,et al. 2014. Direct assessment of hepaticmitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy. Nat. Med. 20:98-102
9. Begriche K, Igoudjil A, Pessayre D, Fromenty B. 2006. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6:1-28
10. Benard G, Faustin B, Passerieux E, Galinier A, Rocher C, et al. 2006. Physiological diversity of mitochondrial oxidative phosphorylation. Am. J. Physiol. Cell Physiol. 291:C1172-82
11. Bhat G, Baba CS, Pandey A, Kumari N, Choudhuri G. 2012. Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease. World J. Hepatol. 4:209-17
12. Bogacka I, Xie H, Bray GA, Smith SR. 2005. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54:1392-99
13. Bouderba S, Sanz MN, Sánchez-Martín C, El-Mir MY, Villanueva GR, et al. 2012. Hepatic mitochondrial alterations and increased oxidative stress in nutritional diabetes-prone Psammomys obesus model. Exp. Diabetes Res. 2012:430176
14. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, et al. 2007. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56:2457-66
15. Boushel R,Gnaiger E, Schjerling P, Skovbro M, Kraunsøe R, Dela F. 2007. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50:790-96
16. Brady LJ, Brady PS, Romsos DR, Hoppel CL. 1985. Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob/ob) mice. Biochem. J. 231:439-44
17. Brand MD, Nicholls DG. 2011. Assessing mitochondrial dysfunction in cells. Biochem. J. 435:297-312
18. Brehm A, Krssák M, Schmid AI, Nowotny P,Waldhäusl W, RodenM. 2006. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 55:136-40
19. Brehm A, Krssák M, Schmid AI, Nowotny P,Waldhäusl W, Roden M. 2010. Acute elevation of plasma lipids does not affect ATP synthesis in human skeletalmuscle. Am. J. Physiol. Endocrinol. Metab. 299:E33-38
20. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, RobertsMW, et al. 2005. Reduced cardiac efficiency and altered substratemetabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146:5341-49
21. Burgess SC, Merritt ME, Jones JG, Browning JD, Sherry AD, et al. 2015. Limitations of detection of anaplerosis and pyruvate cycling from metabolism of [1-13C] acetate. Nat. Med. 21:108-9
22. Cheng Z, Guo S, Copps K, Dong X, Kollipara R, et al. 2009. Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat. Med. 15:1307-11
23. Chiappini F, Barrier A, Saffroy R, Domart MC, Dagues N, et al. 2006. Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab. Investig. 86:154-65
24. Chmelík M, Schmid AI, Gruber S, Szendroedi J, Krssák M, et al. 2008. Three-dimensional highresolution magnetic resonance spectroscopic imaging for absolute quantification of 31P metabolites in human liver. Magn. Reson. Med. 60:796-802
25. Chomentowski P, Coen PM, Radiková Z, Goodpaster BH, Toledo FG. 2011. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. J. Clin. Endocrinol. Metab. 96:494-503
26. Choudhury J, Sanyal AJ. 2004. Clinical aspects of fatty liver disease. Semin. Liver Dis. 24:349-62
27. Cipolat S, de Brito OM, Dal Zilio B, Scorrano L. 2004. OPA1 requires mitofusin 1 to promote mitochondrial fusion. PNAS 101:15927-32
28. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. 1999. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis a pilot study. JAMA 282:1659-64
29. Cree-Green M, Newcomer BR, Brown MS, Baumgartner AD, Bergman B, et al. 2015. Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance. Diabetes 64:383-92
30. DiamantM,LambHJ, GroeneveldY,Endert EL, Smit JW, et al. 2003. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J. Am. Coll. Cardiol. 42:328-35
31. Elchebly M, Payette P, Michaliszyn E, CromlishW, Collins S, et al. 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544-48
32. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. 2002. Oxidative stress and stress-activated signaling pathways a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23:599-622
33. Fisher-Wellman KH, Weber TM, Cathey BL, Brophy PM, Gilliam LA, et al. 2014. Mitochondrial respiratory capacity and content are normal in young insulin-resistant obese humans. Diabetes 63:132-41
34. Flannery C, Dufour S, Rabol R, Shulman GI, Petersen KF. 2012. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. Diabetes 61:2711-17
35. Frayn KN, Langin D, Karpe F. 2008. Fatty acid-induced mitochondrial uncoupling in adipocytes is not a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is increased. Diabetologia 51:394-97
36. Fritsch M, Koliaki C, Livingstone R, Phielix E, Bierwagen A, et al. 2015. Time course of postprandial hepatic phosphorus metabolites in lean, obese and type 2 diabetes patients. Am. J. Clin. Nutr. 102:1051-58
37. Galgani JE, Vasquez K, Watkins G, Dupuy A, Bertrand-Michel J, et al. 2013. Enhanced skeletal muscle lipid oxidative efficiency in insulin-resistant versus insulin-sensitive nondiabetic, nonobese humans. J. Clin. Endocrinol. Metab. 98:E646-53
38. Galloway CA, Yoon Y. 2013. Mitochondrial morphology in metabolic diseases. Antioxid. Redox Signal. 19:415-30
39. Gancheva S, Koliaki C, Bierwagen A, Nowotny P, Heni M, et al. 2015. Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans. Diabetes 64:1966-75
40. Gao AW, Cantó C, Houtkooper RH. 2014. Mitochondrial response to nutrient availability and its role in metabolic disease. EMBO Mol. Med. 6:580-89
41. Gnaiger E. 2009. Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. Int. J. Biochem. Cell Biol. 41:1837-45
42. Goldstein BJ, Mahadev K,Wu X. 2005. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 54:311-21
43. Gomes LC, Di Benedetto G, Scorrano L. 2011. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 13:589-98
44. Hales KG. 2004. The machinery of mitochondrial fusion, division, and distribution, and emerging connections to apoptosis. Mitochondrion 4:285-308
45. Hales KG, FullerMT. 1997. Developmentally regulated mitochondrial fusion mediated by a conserved, novel, predicted GTPase. Cell 90:121-29
46. Hansen M, Lund MT, Gregers E, Kraunsøe R, Van Hall G, et al. 2015. Adipose tissue mitochondrial respiration and lipolysis before and after a weight loss by diet and RYGB. Obesity (Silver Spring) 23:2022-29
47. Hoehn KL, Salmon AB, Hohnen-Behrens C, Turner N, Hoy AJ, et al. 2009. Insulin resistance is a cellular antioxidant defense mechanism. PNAS 106:17787-92
48. Holloszy JO. 2013. "Deficiency" of mitochondria in muscle does not cause insulin resistance. Diabetes 62:1036-40
49. How OJ, Aasum E, Severson DL, Chan WY, EssopMF, Larsen TS. 2006. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 55:466-73
50. Iozzo P, Bucci M, Roivainen A, Nagren K, Järvisalo MJ, et al. 2010. Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology 139:846-56.e6
51. Jahansouz C, Serrot FJ, Frohnert BI, Foncea RE, Dorman RB, et al. 2015. Roux-en-Y gastric bypass acutely decreases protein carbonylation and increases expression of mitochondrial biogenesis genes in subcutaneous adipose tissue. Obes. Surg. 25:2376-85
52. Jelenik T, Roden M. 2013. Mitochondrial plasticity in obesity and diabetes mellitus. Antioxid. Redox Signal. 19:258-68
53. Jelenik T, Séquaris G, Kaul K, Ouwens DM, Phielix E, et al. 2014. Tissue-specific differences in the development of insulin resistance in a mouse model for type 1 diabetes. Diabetes 63:3856-67
54. Kalyanaraman B, Darley-Usmar V, Davies KJ, Dennery PA, FormanHJ, et al. 2012. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic. Biol. Med. 52:1-6
55. Kelley DE, He J, Menshikova EV, Ritov VB. 2002. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944-50
56. Kelley DE, Mandarino LJ. 2000. Fuel selection in human skeletal muscle in insulin resistance a reexamination. Diabetes 49:677-83
57. Kemp GJ, Brindle KM. 2012. What do magnetic resonance-based measurements of Pi→ATP flux tell us about skeletal muscle metabolism? Diabetes 61:1927-34
58. Koliaki C, Roden M. 2013. Hepatic energy metabolism in human diabetes mellitus, obesity and nonalcoholic fatty liver disease. Mol. Cell. Endocrinol. 379:35-42
59. Koliaki C, Roden M. 2014. Do mitochondria care about insulin resistance? Mol. Metab. 3:351-53
60. Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, et al. 2015. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 21:739-46
61. Kraunsøe R, Boushel R,Hansen CN, Schjerling P,Qvortrup K, et al. 2010. Mitochondrial respiration in subcutaneous and visceral adipose tissue from patients withmorbid obesity. J. Physiol. 588(Part 12):2023-32
62. Kotiadis VN, Duchen MR, Osellame LD. 2014. Mitochondrial quality control and communications with the nucleus are important in maintaining mitochondrial function and cell health. Biochim. Biophys. Acta 1840:1254-65
63. Kotronen A, Seppälä-Lindroos A, Vehkavaara S, Bergholm R, Frayn KN, et al. 2009. Liver fat and lipid oxidation in humans. Liver Int. 29:1439-46
64. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, et al. 2008. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7:45-56
65. Larsen S, Nielsen J, Hansen CN, Nielsen LB, Wibrand F, et al. 2012. Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J. Physiol. 590:3349-60
66. Lee HJ, Chung K, Lee H, Lee K, Lim JH, Song J. 2011. Downregulation of mitochondrial lon protease impairs mitochondrial function and causes hepatic insulin resistance in human liver SK-HEP-1 cells. Diabetologia 54:1437-46
67. Lefort N, Glancy B, Bowen B, Willis WT, Bailowitz Z, et al. 2010. Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normalmitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 59:2444-52
68. LiesaM, Shirihai OS. 2013. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 17:491-506
69. Long YC, Cheng Z, Copps KD, White MF. 2011. Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways. Mol. Cell. Biol. 31:430-41
70. Maassen JA, Romijn JA, Heine RJ. 2007. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia 50:2036-41
71. Machado MV, Ferreira DM, Castro RE, Silvestre AR, Evangelista T, et al. 2012. Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. PLOS ONE 7:e31738
72. Martin SD,Morrison S,Konstantopoulos N, McGee SL. 2014. Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action. Mol. Metab. 3:408-18
73. Metzler B, Schocke MF, Steinboeck P, Wolf C, JudmaierW, et al. 2002. Decreased high-energy phosphate ratios in the myocardium of menwith diabetes mellitus type I. J. Cardiovasc. Magn. Reson. 4:493-502
74. MieleL,GriecoA,Armuzzi A, Candelli M, Forgione A, et al. 2003. Hepaticmitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am. J. Gastroenterol. 98:2335-36
75. Mingrone G, Manco M, Calvani M, Castagneto M, Naon D, Zorzano A. 2005. Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity? Diabetologia 48:2108-14
76. Misu H, Takamura T, Matsuzawa N, Shimizu A, Ota T, et al. 2007. Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia 50:268-77
77. Mitchell T, Chacko B, Ballinger SW, Bailey SM, Zhang J, Darley-Usmar V. 2013. Convergent mechanisms for dysregulation of mitochondrial quality control in metabolic disease: implications for mitochondrial therapeutics. Biochem. Soc. Trans. 41:127-33
78. Mogensen M, Sahlin K, Fernström M, Glintborg D, Vind BF, et al. 2007. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56:1592-99
79. Mohanty JG, Jaffe JS, Schulman ES, Raible DG. 1997. A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J. Immunol. Methods 202:133-41
80. Mollica MP, Lionetti L, Moreno M, Lombardi A, De Lange P, et al. 2009. 3,5-diiodo-L-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. J. Hepatol. 51:363-70
81. Montaigne D, Marechal X, Coisne A, DebryN,Modine T, et al. 2014. Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients. Circulation 130:554-64
82. Mootha VK, Lindgren CM, ErikssonKF, Subramanian A, Sihag S, et al. 2003. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34:267-73
83. Moreno-Navarrete JM, Ortega F, Moreno M, Ricart W, Fernández-Real JM. 2014. Fine-tuned iron availability is essential to achieve optimal adipocyte differentiation and mitochondrial biogenesis. Diabetologia 57:1957-67
84. Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, et al. 2005. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115:3587-93
85. Morris EM, Rector RS,Thyfault JP, Ibdah JA. 2011. Mitochondria and redox signaling in steatohepatitis. Antioxid. Redox Signal. 15:485-504
86. Murphy MP. 2009. How mitochondria produce reactive oxygen species. Biochem. J. 417:1-13
87. Mustelin L, Pietilainen KH, Rissanen A, Sovijarvi AR, Piirila P, et al. 2008. Acquired obesity and poor physical fitness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity. Am. J. Physiol. Endocrinol. Metab. 295:E148-54
88. Nair KS, Bigelow ML, Asmann YW, Chow LS, Coenen-Schimke JM, et al. 2008. Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 57:1166-75
89. Nair S, P Chacko V, Arnold C, Diehl AM. 2003. Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am. J. Gastroenterol. 98:466-70
90. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, et al. 2008. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 48:993-99
91. Paganini AT, Foley JM, Meyer RA. 1997. Linear dependence of muscle phosphocreatine kinetics on oxidative capacity. Am. J. Physiol. 272:C501-10
92. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, et al. 2003. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. PNAS 100:8466-71
93. Pérez-Carreras M, Del Hoyo P, Martín MA, Rubio JC, Martín A, et al. 2003. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38:999-1007
94. Perry CG, Kane DA, Lanza IR, Neufer PD. 2013. Methods for assessing mitochondrial function in diabetes. Diabetes 62:1041-53
95. Perry RJ, Kim T, Zhang X-M, Lee H-Y, Pesta D, et al. 2013. Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. Cell Metab. 18:740-48
96. Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, et al. 2008. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 47:51-58
97. Perseghin G, Ntali G, De Cobelli F, Lattuada G, Esposito A, et al. 2007. Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance. Diabetes Care 30:1520-26
98. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. 2004. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350:664-71
99. Petersen KF, Dufour S, Shulman GI. 2005. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLOS Med. 2:e233
100. Phielix E, Jelenik T, Nowotny P, Szendroedi J, Roden M. 2014. Reduction of non-esterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes a randomised clinical trial. Diabetologia 57:572-81
101. Phielix E, Schrauwen-Hinderling VB, MensinkM, Lenaers E, Meex R, et al. 2008. Lower intrinsic ADPstimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 57:2943-49
102. Ping P, GustafssonA B, Bers DM, Blatter LA, Cai H, et al. 2015. Harnessing the power of integrated mitochondrial biology and physiology a special report on the NHLBI Mitochondria in Heart Diseases Initiative. Circ. Res. 117:234-38
103. Pospisilik JA, Knauf C, Joza N, Benit P, Orthofer M, et al. 2007. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131:476-91
104. Raffaella C, Francesca B, Italia F, Marina P, Giovanna L, Susanna I. 2008. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity 16:958-64
105. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, et al. 1977. Evidence for cardiomyopathy in familial diabetes mellitus. J. Clin. Investig. 60:884-99
106. Rimessi A, Giorgi C, Pinton P, Rizzuto R. 2008. The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death. Biochim. Biophys. Acta 1777:808-16
107. Ritov VB, Menshikova EV, Azuma K, Wood R, Toledo FG, et al. 2010. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am. J. Physiol. Endocrinol. Metab. 298:E49-58
108. Roden M. 2006. Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat. Clin. Pract. Endocrinol. Metab. 2:335-48
109. Rogers GW, Brand MD, Petrosyan S, Ashok D, Elorza AA, et al. 2011. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLOS ONE 6:e21746
110. Romestaing C, Piquet MA, Letexier D, Rey B, Mourier A, et al. 2008. Mitochondrial adaptations to steatohepatitis induced by a methionine-and choline-deficient diet. Am. J. Physiol. Endocrinol. Metab. 294:110-19
111. Samuel VT, Petersen KF, Shulman GI. 2010. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267-77
112. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, et al. 2001. Nonalcoholic steatohepatitis association of insulin resistance andmitochondrial abnormalities. Gastroenterology 120:1183-92
113. Satapati S, Kucejova B, Duarte JA, Fletcher JA, Reynolds L, et al. 2015. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J. Clin. Invest. 125:4447-62
114. Satapati S, Sunny NE, Kucejova B, Fu X, He TT, et al. 2012. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J. Lipid Res. 53:1080-92
115. Scheuermann-Freestone M, Madsen PL,Manners D, Blamire AM, Buckingham RE, et al. 2003. Abnormal cardiac and skeletalmuscle energy metabolism in patients with type 2 diabetes. Circulation 107:3040-46
116. Schmid AI, Chmelík M, Szendroedi J, Krssák M, Brehm A, et al. 2008. Quantitative ATP synthesis in human liver measured by localized 31P spectroscopy using the magnetization transfer experiment. NMR Biomed. 21:437-43
117. Schmid AI, Szendroedi J, Chmelik M, Krssák M, Moser E, RodenM. 2011. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care 34:448-53
118. Serviddio G, Bellanti F, Tamborra R, Rollo T, Capitanio N, et al. 2008. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury. Gut 57:957-65
119. Serviddio G, Bellanti F, Vendemiale G, Altomare E. 2011. Mitochondrial dysfunction in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol. 5:233-44
120. Shulman GI. 2014. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N. Engl. J. Med. 371:2237-38
121. Starkov AA. 2010. Measurement of mitochondrial ROS production. Methods Mol. Biol. 648:245-55
122. Sunny NE, Parks EJ, Browning JD, Burgess SC. 2011. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 14:804-10
123. Szendroedi J, Chmelik M, Schmid AI, Nowotny P, Brehm A, et al. 2009. Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology 50:1079-86
124. Szendroedi J, Kaul K, Kloock L, Straßburger K, Schmid AI, et al. 2014. Lower fasting muscle mitochondrial activity relates to hepatic steatosis in humans. Diabetes Care 37:468-74
125. Szendroedi J, Phielix E, Roden M. 2011. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 8:92-103
126. Szendroedi J, Roden M. 2008. Mitochondrial fitness and insulin sensitivity in humans. Diabetologia 51:2155-67
127. Szendroedi J, Schmid AI, Chmelik M, KrssakM,Nowotny P, et al. 2011. Skeletal muscle phosphodiester content relates to body mass and glycemic control. PLOS ONE 6:e21846
128. Szendroedi J, Schmid AI, Chmelik M, Toth C, BrehmA, et al. 2007. Muscle mitochondrialATPsynthesis and glucose transport/phosphorylation in type 2 diabetes. PLOS Med. 4:e154
129. Takamura T, Misu H, Matsuzawa-Nagata N, Sakurai M, Ota T, et al. 2008. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients. Obesity (Silver Spring) 16:2601-9
130. TaoH, Zhang Y, Zeng X, Shulman GI, Jin S. 2014. Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice. Nat. Med. 20:1263-69
131. Trevellin E, Scorzeto M, Olivieri M, Granzotto M, Valerio A, et al. 2014. Exercise training induces mitochondrial biogenesis and glucose uptake in subcutaneous adipose tissue through eNOS-dependent mechanisms. Diabetes 63:2800-11
132. Twig G, Hyde B, Shirihai OS. 2008. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim. Biophys. Acta 1777:1092-97
133. Vernochet C, Damilano F,Mourier A, Bezy O,MoriMA, et al. 2014. Adipose tissue mitochondrial dysfunction triggers a lipodystrophic syndrome with insulin resistance, hepatosteatosis, and cardiovascular complications. FASEB J. 28:4408-19
134. VernochetC,Mourier A, BezyO,Macotela Y, Boucher J, et al. 2012. Adipose-specific deletion ofTFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance. Cell Metab. 16:765-76
135. Westermeier F, Navarro-Marquez M, López-Crisosto C, Bravo-Sagua R, Quiroga C, et al. 2015. Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy. Biochim. Biophys. Acta 1853:1113-18
136. Zorzano A, Liesa M, Palacín M. 2009. Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int. J. Biochem. Cell Biol. 41:1846-54
137. Zungu M, Schisler J, Willis MS. 2011. All the little pieces-regulation of mitochondrial fusion and fission by ubiquitin and small ubiquitin-like modifier and their potential relevance in the heart. Circ. J. 75:2513-21